Clinical Utility of Salivary Cytokines for Children with Attention Deficit Hyperactivity Disorder
 G. Polanczyk, M. S.de Lima, B. L. Horta, J. Biederman, L. A. Rohde, “The Worldwide Prevalence of ADHD: a systematic review and metaregression analysis,” Am. J. Psychiatry, vol. 164, no. 6, pp. 942–948, Jun. 2007.
 R. L.Findling, “Evolution of the treatment of attention-deficit/hyperactivity disorder in children: A review,” Clin. Ther., vol. 30, no. 5, pp. 942–957, May. 2008.
 A. A. J. Verlaet, C. M. Maasakkers, N. Hermans, H. F. J. Savelkoul, “Rationale for Dietary Antioxidant Treatment of ADHD,” Nutrients, vol. 10, no. 4). pii. E405, Mar. 2018.
 A. Soltanifar, H. Massoudian, Z. Salimi, F. Moharreri, “The comparison between the levels of pro-inflammatory cytokines in ADHD children with healthy subjects,” J. Child. Adolesc. Psych., vol. 2 no. 3, pp. 3–6, Dec. 2018.
 A. H. Darwish, T. M. Elgohary, N. A. Nosair, “Serum Interleukin-6 Level in Children With Attention-Deficit Hyperactivity Disorder (ADHD),” J. Child. Neurol., vol. 34, no. 2, pp.61–67, Feb. 2019.
 B. B. Mittleman, F. X. Castellanos, L. K. Jacobsen, J. L. Rapoport, S. E. Swedo, G. M. Shearer, “Cerebrospinal Fluid Cytokines in Pediatric Neuropsychiatric Disease,” J. Immunol., vol. 159, no. 6, pp.2994–2999, Sep. 1997.
 R. H. Mitchell, B. I.Goldstein, “Inflammation in children and adolescents with neuropsychiatric disorders: A systematic review,” J Am Acad Child Adolesc Psych., vol. 53, no. 3, pp. 274–296, Mar. 2014.
 I. Tomas, N. Arias-Bujanda, M. Alonso-Sampedro, M.A. Casares-de-Cal, C. Sanchez-Sellero, D. Suarez-Quintanilla, C. Balsa-Castro, “Cytokine-based predictive models to estimate the probability of chronic periodontitis: Development of diagnostic nomograms,” Sci. Rep., 7: 11580, 2017.
 T. Koizumi, V. Shetty, and M. Yamaguchi, “A Salivary Cytokine Panel Indicative of Non-small Cell Lung Cancer,” J. Int. Med. Res., vol.46, no.9, pp. 3570-3582, Jun. 2018.
 S. Daly, D. Rinewalt, C. Fhied, S. Basu, B. Mahon, M. J. Liptay, E. Hong, G. Chmielewski, M. A. Yoder, P. N. Shah, E. S. Edell, F. Maldonado, A. O. Bungum, J. A. Borgia, “Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules,” J. Thorac. Oncol., IASLC vol. 8, no. 1, pp.31–36, Jan. 2013.
 C. DeCotiis, Y. Hu, A. K. Greenberg, M. Huie, J. J. Tsay, H. Pass, J. D. Goldberg, W. N. Rom, “Inflammatory cytokines and non-small cell lung cancer in a CT-scan screening cohort: Background review of the literature,” Cancer Biomark., vol. 16, no. 2, pp. 219–233, Feb. 2016.
 M. Yamaguchi, S. Okamura, T. Yamaji, M. Iwasaki, S. Tsugane, V. Shetty, T. Koizumi, “Plasma Cytokine Levels and the Presence of Colorectal Cancer,” PLoS ONE, vol.14, no.3, p. e0213602, Mar. 2019.
 S. Kezic, G. M. O’Regan, R. Lutter, I. Jakasa, E. S. Koster, S. Saunders, P. Caspers, P. M. J. H. Kemperman, G. J. Puppels, A. Sandilands, H. Chen, L/ E/ Campbell, K. Kroboth, R. Watson, P. G. Fallon, W. H. I. McLean, A. D. Irvine, “Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency,” J. Allergy Clin. Immunol., vol. 129, no. 4, pp. 1031–1039, Apr. 2012.
 M. Attur, H-Y. Wang, V. B. Kraus, J. Bukowski, N. Aziz, S. Krasnokutsky, J. Samuels, J. Greenberg, G. McDaniel, S. B. Abramson, K. S. Kornman, “Radiographic severity of knee osteoarthritis is conditional on interleukin 1 receptor antagonist gene variations,” Ann. Rheum. Dis., vol. 69, no. 5, pp.856–861, 2010.
 R. M. O’Brien, “A caution regarding rules of thumb for variance inflation factors,” Qual. Quant., vol. 41, no. 5, pp. 673–690, Oct. 2007.
 H. F. Dvorak, “Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy,” J. Clin. Oncol., vol. 20, no. 21, pp.4368–4380, Nov. 2002.
 B. Budziszewska, A. Basta-Kaim, M. Kubera, W. Lasoń, “Immunological and endocrinological pattern in ADHD etiopathogenesis,” Przegl. Lek., vol. 67, no. 11, pp.1200–204, 2010
 J. Thome, A. Ehlis, A. J. Fallgatter, K. Krauel, K. W. Lange, P. Riederer, M. Romanos, R. Taurines, O. Tucha, M. Uzbekov, M. Gerlach, “Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD,” World J.Biol.Psychia., vol.13, no.5, pp.379–400, 2012.